223 related articles for article (PubMed ID: 11020406)
21. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension.
Carlsson AM; Chauhan BC; Lee AA; LeBlanc RP
Am J Ophthalmol; 2000 Mar; 129(3):297-301. PubMed ID: 10704543
[TBL] [Abstract][Full Text] [Related]
22. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
Bowman RJ; Cope J; Nischal KK
Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
[TBL] [Abstract][Full Text] [Related]
23. Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
Manni G; Centofanti M; Sacchetti M; Oddone F; Bonini S; Parravano M; Bucci MG
J Glaucoma; 2004 Apr; 13(2):163-7. PubMed ID: 15097264
[TBL] [Abstract][Full Text] [Related]
24. Bilateral granulomatous uveitis as a side effect of topical brimonidine: two case reports.
Hondeghem K; Augustinus B; De Smet MD
Bull Soc Belge Ophtalmol; 2009; (311):51-2. PubMed ID: 19621555
[No Abstract] [Full Text] [Related]
25. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension [corrected].
Carlsson AM; Chauhan BC; Lee AA; Leblanc RP
Am J Ophthalmol; 1999 Dec; 128(6):697-701. PubMed ID: 10612505
[TBL] [Abstract][Full Text] [Related]
26. [The ocular hypotensive effect and safety of 0.2% brimonidine].
Yu M; Li Y; Ge J
Yan Ke Xue Bao; 2001 Dec; 17(4):235-8. PubMed ID: 12567513
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes.
Mundorf T; Wilcox KA; Ousler GW; Welch D; Abelson MB
Adv Ther; 2003; 20(6):329-36. PubMed ID: 15058750
[TBL] [Abstract][Full Text] [Related]
28. Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma.
Korsch E; Grote A; Seybold M; Soditt V
Eur J Pediatr; 1999 Aug; 158(8):685. PubMed ID: 10445353
[No Abstract] [Full Text] [Related]
29. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
30. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
31. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
[TBL] [Abstract][Full Text] [Related]
33. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
Frampton JE
Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
[TBL] [Abstract][Full Text] [Related]
35. Influence of topical brimonidine on visual field in glaucoma.
Ruiz Lapuente C; Ruiz Lapuente A; Link B
Eur J Ophthalmol; 2001; 11 Suppl 2():S67-71. PubMed ID: 11592534
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of glaucoma with brimonidine (Alphagan 0.2%)].
Detry-Morel M; Dutrieux C
J Fr Ophtalmol; 2000 Oct; 23(8):763-8. PubMed ID: 11033496
[TBL] [Abstract][Full Text] [Related]
37. Side-effect profile of brimonidine tartrate in children.
Al-Shahwan S; Al-Torbak AA; Turkmani S; Al-Omran M; Al-Jadaan I; Edward DP
Ophthalmology; 2005 Dec; 112(12):2143. PubMed ID: 16225927
[TBL] [Abstract][Full Text] [Related]
38. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
Cates CA; Jeffrey MN
Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
[No Abstract] [Full Text] [Related]
39. Brimonidine tartarate 0.2% (Alphagan) associated granulomatous anterior uveitis.
Goyal R; Ram AR
Eye (Lond); 2000 Dec; 14(Pt 6):908-10. PubMed ID: 11584856
[No Abstract] [Full Text] [Related]
40. [Selective α2-agonists in the treatment of glaucoma: pharmacology, efficacy and safety].
Kurysheva NI
Vestn Oftalmol; 2019; 135(2):144-150. PubMed ID: 31215546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
